Can only hope so Tony they've been chasing CD40l for quite a long time the 2 other technology collaborators prior to Pepscan where also following the taregt. Isogenica in early 2012 utilising CIS display to optimise the peptide the same as Pepscan in May '11 linking to optimise it through CLIPS & XL-Protein in Jan 2011 to improve the half-life, from what i understand all where initally focussing on CD40l as the intial target with an option to expand the partnerships at a later date. But again still not much released to show progress on any to date apart from Isogenica succesfuly hitting all targets with CD40 in the release Feb '11 & a view to expand the collaboration yet 18 months later and not another word ? but i guess 3 months later they partnered Pepscan - so does that say Isogenicas optimisation despite being released as hitting all targets turned up trumps so they went to Pepscan for another run ? ?
PYC Price at posting:
2.8¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)